Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avanos Medical (AVNS)
NYSE:AVNS
Avanos Medical (AVNS) Stock Price & Analysis
162 Followers
AVNS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.24 - $24.54
Previous Close$23.14
Volume18.11K
Average Volume (3M)207.31K
Market Cap
$1.05B
Enterprise Value$1.20B
Total Cash (Recent Filing)$75.80M
Total Debt (Recent Filing)$214.70M
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Jul 31, 2024EPS Estimate
$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding45,903,911
10 Day Avg. Volume266,664
30 Day Avg. Volume207,314
Standard Deviation0.11
R-Squared0.22
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.47
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)17.70
P/FCF Ratio22.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.77
Enterprise Value/Gross Profit3.16
Enterprise Value/Ebitda19.16
Forecast
1Y Price Target
$23.00Price Target Upside0.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Avanos Medical News
PremiumCompany Announcements
Avanos Medical Appoints New Director to Bolster Governance
PremiumCompany Announcements
Avanos Medical Appoints New SVP for Supply Chain Optimization
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal quarterly revenue came in just ahead of the company's early January preliminary expectations.
Long-Term GoalsManagement highlighted the progress AVNS is making towards future sales growth, margin expansion and meaningful free cash flow.
Strategic InitiativesThe stock gapped up significantly as management has made progress against its strategic initiatives and financial targets.
Bears Say
Business Segment ChallengesThe company's high-margin hyaluronic acid pain relief business is facing continued pricing pressure.
Earnings MissPreliminary 4Q23 top-line results showed a revenue decline, missing consensus estimates.
Financial GuidanceAnnual sales guidance for 2024 was lowered by $20 million due to continued disruption within its HA business.
---
Ownership Overview
2.97% Insiders
34.12% Mutual Funds
30.11% Other Institutional Investors
32.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVNS FAQ
What was Avanos Medical’s price range in the past 12 months?
Avanos Medical lowest stock price was $17.23 and its highest was $24.54 in the past 12 months.
What is Avanos Medical’s market cap?
Currently, no data Available
When is Avanos Medical’s upcoming earnings report date?
Avanos Medical’s upcoming earnings report date is Jul 31, 2024 which is in 2 days.
How were Avanos Medical’s earnings last quarter?
Avanos Medical released its earnings results on May 02, 2024. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.213 by -$0.023.
Is Avanos Medical overvalued?
According to Wall Street analysts Avanos Medical’s price is currently Undervalued.
Does Avanos Medical pay dividends?
Avanos Medical does not currently pay dividends.
What is Avanos Medical’s EPS estimate?
Avanos Medical’s EPS estimate is $0.29.
How many shares outstanding does Avanos Medical have?
Avanos Medical has 45,903,910 shares outstanding.
What happened to Avanos Medical’s price movement after its last earnings report?
Avanos Medical reported an EPS of $0.19 in its last earnings report, missing expectations of $0.213. Following the earnings report the stock price went up 4.896%.
Which hedge fund is a major shareholder of Avanos Medical?
Among the largest hedge funds holding Avanos Medical’s share is Gotham Asset Management LLC. It holds Avanos Medical’s shares valued at 677K.
---
Avanos Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$23.00 (0.48% Upside)
$23.00 (0.48% Upside)
Blogger Sentiment
Bullish
AVNS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 4.6K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.58%
12-Months-Change
Fundamentals
Return on Equity
-0.13%
Trailing 12-Months
Asset Growth
-4.24%
Trailing 12-Months
Company Description
Avanos Medical
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
---
AVNS Company Deck
---
AVNS Earnings Call
Q1 2024
0:00 / 0:00
---
AVNS Stock 12 Month Forecast
Average Price Target
$23.00
▲(0.48% Upside)
Technical Analysis
Best Analysts Covering AVNS
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+16.30%
reiterated a buy rating 3 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.30% per trade.
---